METTL1 and cancer: Another study demonstrated that the reduction of METTL1/WDR4 hinders the translational efficacy of the oncogene lysyl oxidase-like 2 (LOXL2), which is a cancer-causing enzyme that promotes the cross-linking of elastin and collagen in the extracellular matrix.